Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
MA Lawmakers to Weigh Four-Day Work Week The Massachusetts House Labor and Workforce Development Committee scheduled a hearing last week on legislation ( HB 3849 ) that would provide tax credits to businesses...
Bills to Overhaul Long-Term Care and Control Prescription Drug Costs on Move in MA The Massachusetts House unanimously passed a bill ( HB 4178 ) that would overhaul the long-term care industry, while...
OpenAI Ousts CEO Sam Altman The board of directors of OpenAI, developer of ChatGPT, announced on the company’s blog last week that its CEO Sam Altman would be stepping down. The blog post said...
For more than half a year, labor strife has swept the country. First, Hollywood writers went on strike in May. Then actors joined them in walking off the set a couple months later, in July. Detroit...
IL Lawmakers Approve Bill Lifting Moratorium on Nuclear Power Plants: The Illinois General Assembly passed legislation ( HB 2437 ) that, as amended, will lift a nearly four-decades-old moratorium on new...
A bill (SB 410) debated in the Michigan Senate last week would allow residents and state and local governments to sue drug manufacturers and sellers if their products cause injury. In 1995 the state passed the strongest drug immunity law in the nation, shielding drugmakers and sellers almost entirely from such suits. (BRIDGE MICHIGAN)
This year at least 24 states have enacted legislation dealing with health system consolidation and competition, according to the National Conference of State Legislatures. Among many other things the measures address the review and approval of health system mergers, reforms of health system contracting and certificate of need review. (NCSL)
California Gov. Gavin Newsom vetoed a bill (SB 90) that would have prohibited insurers from charging consumers more than $35 out of pocket for a 30-day supply of insulin. Earlier this year the governor announced the state would be partnering with the nonprofit pharmaceutical company Civica Rx to produce its own insulin, which it plans to sell for $30. (ASSOCIATED PRESS, STATE NET)
American taxpayers are overpaying for Medicare Advantage, or Medicare Part C—under which insurance companies are paid by the federal government to manage patient care—by at least $88 billion per year and possibly as much as $140 billion per year, according to a report published by Physicians for a National Health Program. “Various elements of MA, either by design or by consequence, result in a much higher level of government spending than is necessary to provide Medicare benefits, with much of this money going toward corporate profits,” the report states. (MEDICAL ECONOMICS)
—Compiled by SNCJ Managing Editor KOREY CLARK